-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Tevogen Bio Holdings Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q4 2023.
- Tevogen Bio Holdings Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was -$181K, a 106% decline year-over-year.
- Tevogen Bio Holdings Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $2.21M, a 58.8% decline year-over-year.
- Tevogen Bio Holdings Inc. annual Nonoperating Income (Expense) for 2023 was $2.21M, a 58.8% decline from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)